gimli

MAKERSL stock AI analysis

MAKERSL Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

MAKERS LABORATORIES LTD. is a small-cap stock in Healthcare. This Gimli page shows the latest available MAKERSL price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive MAKERSL stock page

Price

₹177.07

1W return

-3.50%

1M return

-4.23%

3M return

n/a

6M return

n/a

1Y return

n/a

Market cap

₹n/a

n/a

ROE

+1.98%

ROCE

+9.58%

RSI

46.00

Turnover

₹0.05 cr

Why it can matter in screens

Momentum: MAKERSL is below 50DMA, below 200DMA; RSI is 46.00.
Returns: 1D -1.35%, 1W -3.50%, 1M -4.23%, 3M n/a, 1Y n/a.
Trend levels: 52W high ₹236.00, 52W low ₹150.00, off high -24.97%.
Liquidity: latest turnover is ₹0.05 cr; volume vs 20D is +1.22%.
Valuation/profitability: PE n/a, PB n/a, ROE +1.98%, ROCE +9.58%.
Growth: 3Y sales CAGR +11.43%, 3Y profit CAGR n/a.

Quick Answers

What is the latest MAKERSL stock price?

The latest stored price for MAKERSL is Rs 177.07 as of 2026-10-09.

Is MAKERSL above its 50DMA and 200DMA?

MAKERSL is below 50DMA, below 200DMA. The latest 50DMA is n/a and the latest 200DMA is n/a.

What are MAKERSL PE, ROE and ROCE?

MAKERSL has PE n/a, ROE +1.98%, and ROCE +9.58% in Gimli's latest available snapshot.

How has MAKERSL performed recently?

MAKERSL has returned -4.23% over 1 month, n/a over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-03-31	35.75 cr	6.03 cr	1.09 cr	n/a
2025-12-31	35.67 cr	4.49 cr	0.94 cr	n/a
2025-09-30	34.17 cr	2.64 cr	-0.12 cr	n/a
2025-06-30	35.00 cr	3.28 cr	0.44 cr	n/a
2025-03-31	33.90 cr	3.19 cr	-0.05 cr	n/a

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	139.53 cr	16.45 cr	2.35 cr	3.99
2025-03-31	120.03 cr	19.48 cr	7.49 cr	12.70
2024-03-31	103.76 cr	2.58 cr	-6.26 cr	-10.62
2023-03-31	100.84 cr	5.52 cr	-4.75 cr	-7.90

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	166.62 cr	0.20 cr	6.12 cr	122.48 cr
2025-03-31	147.95 cr	0.24 cr	5.06 cr	115.19 cr
2024-03-31	161.26 cr	0.41 cr	19.49 cr	104.34 cr
2023-03-31	152.29 cr	0.72 cr	13.42 cr	109.67 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	14.29 cr	10.58 cr	n/a
2025-03-31	-4.08 cr	-8.02 cr	n/a
2024-03-31	0.84 cr	-5.78 cr	n/a
2023-03-31	-8.62 cr	-21.53 cr	n/a

Shareholding Trend

No recent data available.

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	422,282.96 cr	34.857273	+15.50%	+6.12%
DIVISLAB	DIVI S LABORATORIES LTD	247,947.67 cr	85.088426	+18.37%	+52.32%
TORNTPHARM	TORRENT PHARMACEUTICALS L	157,610.64 cr	72.265309	+17.33%	+31.16%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	115,423.17 cr	58.937484	+21.03%	+4.32%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	112,446.65 cr	25.058308	+16.04%	+12.37%
LAURUSLABS	LAURUS LABS LIMITED	109,947.20 cr	100.670416	+21.77%	+135.42%
CIPLA	CIPLA LTD	105,094.85 cr	31.162389	+10.25%	-14.02%
DRREDDY	DR. REDDY S LABORATORIES	99,661.60 cr	30.096514	+9.23%	-3.94%

Try these prompts

Analyze MAKERS LABORATORIES. with valuation, momentum and industry peers
Compare MAKERSL with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-10-09. Not investment advice.